Global Defibrillators Market - 2024-2031

Report Overview

The Global Defibrillators Market reached US$ 12.88 billion in 2023 and is expected to reach US$ 22.29 billion by 2031 growing with a CAGR of 7.1%% during the forecast period 2024-2031.

Defibrillators are critical medical devices that deliver an electric shock or pulse to the heart to restore a normal heartbeat, particularly in cases of cardiac arrest, also known as sudden cardiac arrest (SCA). When the heart's rhythm ceases due to conditions such as ventricular fibrillation or pulseless ventricular tachycardia, a defibrillator can help restart the heart. A sudden cardiac arrest is fatal unless treated immediately with cardiopulmonary resuscitation (CPR) and the use of a defibrillator.

Defibrillators function by delivering an electric shock to the heart muscle. This shock depolarizes a significant portion of the heart tissue, effectively disrupting the disordered electrical activity that leads to arrhythmias. The primary aim is to reset the heart's electrical system, enabling it to regain a normal rhythm. The main arrhythmias that defibrillators target are ventricular fibrillation and pulseless ventricular tachycardia.

Market Dynamics: Drivers

Increasing prevalence of cardiovascular diseases (CVDs) and technological advancements

The demand for the global defibrillators market is driven by multiple factors. One of the key factors is the increasing prevalence of cardiovascular diseases (CVDs) and technological advancements. Cardiovascular diseases (CVDs) are the foremost cause of death worldwide. The increasing occurrence of cardiovascular diseases (CVDs), such as coronary artery disease and heart failure, is a major factor driving the growth of the defibrillator market.

According to the WHO data in May 2024, Cardiovascular diseases (CVDs) are the primary cause of disability and premature death in the European Region, accounting for over 42.5% of all annual deaths, which translates to approximately 10,000 fatalities each day. As per the report from WHO/Europe, men in this region are nearly 2.5 times more likely to succumb to CVD compared to women.

Additionally, there is a marked geographic disparity; the likelihood of dying young (between the ages of 30 and 69) from a CVD is almost five times greater in Eastern Europe and Central Asia than in Western Europe. With cardiovascular diseases (CVDs) being the foremost cause of death and disability in Europe, there is an urgent requirement for immediate access to defibrillation during cardiac emergencies.

Moreover, continuous innovations in defibrillator technology are significantly enhancing device efficiency and user-friendliness, which is crucial for improving patient outcomes during cardiac emergencies. Modern defibrillators, particularly Implantable Cardioverter Defibrillators (ICDs) and Automated External Defibrillators (AEDs), now incorporate advanced features that facilitate better monitoring and treatment of patients at risk of sudden cardiac arrest.

In addition, government initiatives such as awareness programs and the introduction of innovative product launches are driving this market growth. For instance, in July 2023, the Uttar Pradesh government announced a significant initiative to improve public health by installing Automated External Defibrillators (AEDs) in all government buildings, malls, and other public places, including the Uttar Pradesh Secretariat. This initiative aims to provide essential first aid to individuals experiencing cardiac arrest.

Also, in January 2023, Mindray announced the launch of its next-generation BeneHeart series defibrillators, specifically the BeneHeart D60 and D30 models. These advanced devices are designed to elevate the standards of resuscitation by offering superior reliability, comprehensive diagnostic capabilities, and monitoring tools. The introduction of these defibrillators aims to provide a complete quality improvement solution for both in-hospital and pre-hospital emergencies.

Restraints

Factors such as product recalls, the high cost of devices, concerns associated with the usage of devices, lack of skilled professionals, and regulatory challenges are expected to hamper the market.

Market Segment Analysis

The global defibrillators market is segmented based on product type, age group, end-user, and region.

The external defibrillators segment accounted for approximately 73.3% of the global defibrillators market share

The external defibrillators segment is expected to hold the largest market share over the forecast period. External defibrillators are medical devices designed to deliver an electric shock to the heart to restore its normal rhythm during life-threatening cardiac arrhythmias, such as ventricular fibrillation and pulseless ventricular tachycardia.

These devices are essential for treating sudden cardiac arrest (SCA), a condition where the heart unexpectedly stops functioning effectively. External defibrillators include manual external defibrillators, wearable cardioverter defibrillators, and automated external defibrillators (AEDs).

Moreover, key players in the region, product launches, and awareness programs help to propel this segment's growth in the market. For instance, in March 2024, Stryker, a leading global medical technology company, participated in the Criticare National Conference, which took place at the ITC Royal Bengal in Kolkata, India. During this event, Stryker launched and showcased two innovative products: LIFEPAK CR2 automated external defibrillator (AED) and the Evacuation Chair designed for emergency patient evacuation.

The LIFEPAK CR2 is an innovative defibrillator that empowers rescuers to deliver high-quality CPR and provide immediate shocks during sudden cardiac arrest (SCA) emergencies. This revolutionary device is designed to enhance the ability of rescuers to provide life-saving care to victims of sudden cardiac arrest.

Similarly, in January 2024, Speedy Hire initiated a life-saving program to equip its engineer vans across the UK with Automated External Defibrillators (AEDs). The rollout starts with the installation of 18 defibrillators, with plans to expand this to over 300 portable devices in the vans of Speedy Hire's engineers. This initiative aims to address the concerning statistic that more than 30,000 individuals in the UK suffer from out-of-hospital cardiac arrests annually, with less than 10% surviving. By providing AEDs in their vans, Speedy Hire intends to enhance immediate response capabilities during emergencies, ensuring that help is readily available when needed.

Market Geographical Analysis

North America accounted for approximately 43.7% of the global defibrillators market share

North America region is expected to hold the largest market share over the forecast period owing to the increasing occurrence of cardiovascular diseases, such as heart attack, heart failure, and coronary heart disease, which is a significant driver of market growth in North America.

Heart disease is the primary cause of mortality for men, and women, in the United States. In 2022, cardiovascular disease claimed the lives of 702,880 people, which translates to one death every 33 seconds and accounts for approximately one out of every five deaths nationwide.

Moreover, awareness campaigns and government initiatives propel the significance of automated external defibrillators (AEDs) fueling market growth in North America. Numerous states in the U.S. have enacted laws mandating the installation of AEDs in specific public locations, including highway rest areas, government buildings, public safety vehicles, hotels, urgent care centers, and retail health clinics.

Additionally, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, technological advancements, and product launches & approvals would propel this Market growth. For instance, in October 2023, Medtronic received FDA approval for its Aurora Extravascular Implantable Cardioverter Defibrillator (EV-ICD), an innovative device designed to treat abnormal heart rhythms and prevent sudden cardiac arrest (SCA). This innovative defibrillator represents a significant advancement in cardiac care technology.

Also, in January 2023, Avive Solutions received pre-market approval (PMA) from the U.S. Food and Drug Administration (FDA) for its innovative Avive AED, a unique Automated External Defibrillator (AED). This approval signifies a major advancement in cardiac emergency response technology.

The Avive AED is a pioneering device that integrates cellular, WiFi, GPS, and Bluetooth connectivity into a compact, handheld format. This suite of connectivity features powers Avive's groundbreaking REALConnect Technology, which is designed to seamlessly connect with 911 emergency centers through a collaboration with RapidSOS. As a result, the device can transmit critical incident data to 911 dispatchers, emergency medical services (EMS), and healthcare professionals in real-time, enhancing situational awareness and optimizing emergency response efforts.

Market Segmentation

By Product Type

Implantable Cardioverter Defibrillators (ICDs)

Transvenous Implantable Cardioverter Defibrillators (T-ICDs)

Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)

Cardiac Resynchronization Therapy Defibrillators (CRT-D)

External Defibrillators

Manual External Defibrillators

Wearable Cardioverter Defibrillators

Automated External Defibrillators (AEDs)

Semi-Automated AEDs

Fully Automated AEDs

By Age Group

Pediatrics

Adults

By End-User

Hospitals

Cardiac Centers

Homecare Settings

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the defibrillators market include Medtronic, Boston Scientific Corporation, Abbott, Koninklijke Philips N.V., Stryker, NIHON KOHDEN CORPORATION, Mindray Medical India Pvt. Ltd., MicroPort Scientific Corporation., ZOLL Medical Corporation, and Biotronik among others.

Key Developments

In June 2024, the launch of the first-ever Hato Hone St John branded defibrillators represents a significant advancement in emergency cardiac care technology. These new Automated External Defibrillators (AEDs), developed in partnership with medical technology manufacturer ViVest, are designed to deliver a shock to a patient in as little as seven seconds, which is crucial during sudden cardiac arrest (SCA) situations.

In May 2024, London Hearts, a leading defibrillator charity in the UK, announced the launch of a new scheme aimed at making defibrillators more accessible and affordable to communities across the country. The charity provides funding through grants to help organizations and communities acquire these life-saving devices. The scheme is a significant step towards making defibrillators more affordable and widely available throughout the UK.

In October 2023, MicroPort CRM announced the launch of the ULYS Implantable Cardioverter Defibrillator (ICDs) and INVICTA defibrillation lead in Japan. Both devices are MRI conditional at 1.5T and 3T when implanted as a system. This advanced technology ensures low current consumption, leading to a predicted lifespan that is up to 8 years longer than other ICD devices. Additionally, the ULYS incorporates the PARAD+ arrhythmia discrimination algorithm, which has been clinically proven to have the lowest rate of inappropriate shocks.

Why Purchase the Report?

To visualize the global defibrillators market segmentation based on product type, age group, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the defibrillators market with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The global defibrillators market report would provide approximately 62 tables, 51 figures, and 183 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies